Retractable Technologies (NYSE:RVP) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

NYSE:RVP opened at $0.76 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 9.51 and a quick ratio of 6.54. The business’s 50-day moving average price is $0.86 and its two-hundred day moving average price is $1.01. Retractable Technologies has a 1-year low of $0.71 and a 1-year high of $1.34.

Retractable Technologies (NYSE:RVP) last released its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) EPS for the quarter. The business had revenue of $6.03 million for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%.

Insider Transactions at Retractable Technologies

In other Retractable Technologies news, CEO Thomas J. Shaw purchased 71,422 shares of the company’s stock in a transaction dated Friday, September 20th. The shares were bought at an average price of $0.82 per share, with a total value of $58,566.04. Following the completion of the transaction, the chief executive officer now directly owns 14,743,907 shares in the company, valued at $12,090,003.74. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have acquired a total of 181,732 shares of company stock valued at $160,899 over the last 90 days. 55.00% of the stock is owned by company insiders.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.